Charcot-Marie-Tooth Clinical Trials

4 recruiting

Charcot-Marie-Tooth Trials at a Glance

10 actively recruiting trials for charcot-marie-tooth are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Houston, Milan, and Boston. Lead sponsors running charcot-marie-tooth studies include Centre Hospitalier Universitaire de Liege, Children's Hospital of Philadelphia, and Assistance Publique Hopitaux De Marseille.

Browse charcot-marie-tooth trials by phase

Treatments under study

About Charcot-Marie-Tooth Clinical Trials

Looking for clinical trials for Charcot-Marie-Tooth? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Charcot-Marie-Tooth trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Charcot-Marie-Tooth clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 1

A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.

Charcot-Marie-Tooth Disease, Type 1A
Novartis Pharmaceuticals28 enrolled3 locationsNCT07140614
Recruiting

Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Charcot-Marie-ToothCMT1A+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta39 enrolled1 locationNCT07461896
Recruiting
Not Applicable

Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers

Myotonic DystrophyMuscular DystrophyCharcot-Marie-Tooth+1 more
Institut de Myologie, France30 enrolled1 locationNCT07321977
Recruiting

The Myelin Disorders Biorepository Project

AdrenoleukodystrophyCockayne SyndromeRefsum Disease+63 more
Children's Hospital of Philadelphia12,000 enrolled23 locationsNCT03047369
Recruiting

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Charcot-Marie-Tooth Disease, Type Ia (Disorder)HMSN
University of Iowa1,050 enrolled22 locationsNCT01193088
Recruiting

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

Metabolic DiseaseAMPD3, OMIM*102772, AMP Deaminase DeficiencyAK1, OMIM *103000, Adenylate Kinase Deficiency+25 more
National Human Genome Research Institute (NHGRI)999 enrolled1 locationNCT06092346
Recruiting
Not Applicable

Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients

Charcot-Marie-Tooth Neuropathy Type 1AHereditary Transthyretin Amyloid NeuropathyAcquired Demyelinating Neuropathy
Assistance Publique Hopitaux De Marseille120 enrolled1 locationNCT06845644
Recruiting
Not Applicable

Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study

Duchenne Muscular DystrophyFascioscapulohumeral Muscular DystrophyCentronuclear Myopathy+3 more
Centre Hospitalier Universitaire de Liege300 enrolled8 locationsNCT05982119
Recruiting
Phase 2

A randomised phase II study to evaluate the effectiveness of botulinum toxin to delay, and possibly prevent, progressive foot deformities in children with Charcot-Marie-Tooth (CMT) disease.

Charcot-Marie-Tooth disease
The Children's Hospital at Westmead10 enrolled1 locationACTRN12605000115639
Recruiting

Night casting and stretching to improve function in people with Charcot-Marie-Tooth disease

Charcot-Marie-Tooth disease
University of Sydney30 enrolled1 locationACTRN12605000011684